DianaPeta-GayEnglishMD

Obstetrics & Gynecology • Tampa, FL

Gynecologic Oncology, Hospice & Palliative Medicine

Clinical Assistant Professor, University of South Florida

Join to view full profile

Dr. English is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. English's full profile

Already have an account?

Office
2 Tampa General Cir
Tampa, FL 33606
Phone+1 813-974-2201

Fax+1 813-844-5882

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Hospice and Palliative Medicine, 2018 - 2019
Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2012 - 2015
University of Miami/Jackson Health SystemResidency, Obstetrics and Gynecology, 2008 - 2012
University of the West Indies Faculty of Medical SciencesClass of 2005

Certifications & Licensure

FL State Medical License 2018 - 2026
CA State Medical License 2015 - 2019
CT State Medical License 2012 - 2015
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

7 citations
Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterin...
Liancheng Zhu, Salvatore Lopez, Stefania Bellone, Jonathan Black, Emiliano Cocco
Tumour Biology. 2015-02-11
158 citations
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition
Siming Zhao, Stefania Bellone, Salvatore Lopez, Durga Thakral, Carlton L. Schwab
Proceedings of the National Academy of Sciences of the United States of America. 2016-10-25
30 citations
Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivo
Salvatore Lopez, Carlton L. Schwab, Emiliano Cocco, Stefania Bellone, Elena Bonazzoli
Gynecologic Oncology. 2014-11-01

Press Mentions

Britney Spears Conservatorship: What Are IUDs, Risk Factors?July 8th, 2021